1. Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci 
L.M. Deshpande, R.N. Jones 
Clinical Microbiology and Infection 
Volume 9, Issue 11, Pages (November 2003)
DOI: /j x
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Time–kill curve for Streptococcus pneumoniae C (BAL9141 MIC, mg/L) using BAL9141 concentrations of 4, 8 and 16 mg/L.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
Time–kill curve for Staphylococcus aureus 82-11A (BAL9141 MIC, 0.25 mg/L) using BAL9141 concentrations of 4, 8 and 16 mg/L. All concentrations achieved bactericidal action, but an ‘Eagle effect’ was detected.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
BAL9141 synergy experiment with gentamicin (MIC/4) using E. faecium A (ampicillin and vancomycin susceptible).
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions